Evidence map›Paper›PMID 42154849›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2026

Weil's disease: rapid recovery following corticosteroid treatment: a case report.

Ahmet Melih Şahin, İrem Atçı-Koç, Sinan Çetin

Abstract readCase Reports
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmet Melih ŞahinGiresun University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, Giresun, Turkey.ORCID http://orcid.org/0000-0003-3670-7801
İrem Atçı-KoçGiresun University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, Giresun, Turkey.ORCID http://orcid.org/0009-0000-0657-7095
Sinan ÇetinGiresun University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, Giresun, Turkey.ORCID http://orcid.org/0000-0002-0673-9354

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptospirosis is a zoonotic infection with a range of clinical findings, ranging from a mild, self-limited illness to a severe, life-threatening disease known as Weil's disease. The role of adjunctive corticosteroid therapy in severe leptospirosis remains controversial. We report a 41-year-old male with a history of intravenous drug use, regular alcohol consumption, and exposure to contaminated freshwater, who presented with fever, myalgia, vomiting, jaundice, thrombocytopenia, and acute kidney injury. Serological testing via the microagglutination test (MAT) was negative at admission, and empirical antibiotic therapy with ceftriaxone was initiated. Despite appropriate antimicrobial treatment and supportive care, including hemodialysis, the patient developed progressive hyperbilirubinemia and persistent thrombocytopenia. A repeat MAT performed one week later confirmed infection with Leptospira interrogans serovar Pomona. Due to ongoing clinical deterioration, methylprednisolone (1 mg/kg/day) was initiated, resulting in a dramatic clinical and laboratory improvement within 24 h. This rapid response suggests a potential role for corticosteroid therapy in selected patients with severe leptospirosis; however, further studies are required to establish its efficacy and safety.

Indexed as

Anti-Inflammatory AgentsGlucocorticoidsMethylprednisoloneWeil DiseaseAdultAnti-Bacterial AgentsHumansMaleTreatment OutcomeAnti-Bacterial AgentsAnti-Inflammatory AgentsGlucocorticoidsMethylprednisolone

Identifiers

PMID42154849
PMCPMC13183348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.